Literature DB >> 12626284

Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery.

A Sablotzki1, M G Dehne, I Friedrich, S Grond, B Zickmann, J Mühling, R E Silber, E G Czeslick.   

Abstract

OBJECTIVE: Cardiopulmonary bypass is often associated with pathophysiological changes in form of systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome (MODS). In the present study, we investigated plasma levels of pro- and anti-inflammatory cytokines in survivors and non-survivors from MODS in the early postoperative course following open heart surgery.
DESIGN: Prospective clinical study.
SETTING: A University Cardiothoracic Intensive Care Unit.
METHODS: Levels of cytokines (IL-6, IL-8, IL-10, IL-18, and TGF- ) and procalcitonin (PCT) were measured at the first four postoperative days in 16 adult male patients with an Apache II-score >24 and two or more organ dysfunctions after myocardial revascularization. MAIN
RESULTS: All pro-inflammatory cytokines, except for IL-6, were significantly elevated in non-survivors from MODS, with peak values at the first two postoperative days. The plasma levels of immunoinhibitory cytokines showed no differences between the groups.
CONCLUSIONS: The results of our study show a different expression of pro-inflammatory cytokines in survivors and non-survivors from MODS following operations with extracorporeal circulation. In addition to Apache-II score, especially IL-8, IL-18, and PCT may be used as parameters for the prognosis of patients with organ dysfunctions after cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626284

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  8 in total

1.  Heterogeneity in lipopolysaccharide responsiveness of endothelial cells identified by gene expression profiling: role of transcription factors.

Authors:  G C Beck; N Rafat; P Brinkkoetter; C Hanusch; J Schulte; M Haak; K van Ackern; F J van der Woude; B A Yard
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

2.  Serial cytokine levels in patients with severe sepsis.

Authors:  Huang-Pin Wu; Chian-Kuang Chen; Kong Chung; Jo-Chi Tseng; Chung-Ching Hua; Yu-Chih Liu; Duen-Yau Chuang; Chung-Han Yang
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

3.  Ulinastatin, a protease inhibitor, may inhibit allogeneic blood transfusion-associated pro-inflammatory cytokines and systemic inflammatory response syndrome and improve postoperative recovery.

Authors:  Haihua Shu; Kuanzhi Liu; Qiulan He; Fei Zhong; Lu Yang; Qiaobo Li; Weifeng Liu; Fang Ye; Wenqi Huang
Journal:  Blood Transfus       Date:  2013-05-08       Impact factor: 3.443

4.  Mechanical ventilation interacts with endotoxemia to induce extrapulmonary organ dysfunction.

Authors:  D Shane O'Mahony; W Conrad Liles; William A Altemeier; Shireesha Dhanireddy; Charles W Frevert; Denny Liggitt; Thomas R Martin; Gustavo Matute-Bello
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 5.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.

Authors:  Christoph Sponholz; Yasser Sakr; Konrad Reinhart; Frank Brunkhorst
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Prognostic value of procalcitonin in patients after elective cardiac surgery: a prospective cohort study.

Authors:  Matthias Klingele; Hagen Bomberg; Simone Schuster; Hans-Joachim Schäfers; Heinrich Volker Groesdonk
Journal:  Ann Intensive Care       Date:  2016-11-23       Impact factor: 6.925

7.  Novel polymorphism of interleukin-18 associated with greater inflammation after cardiac surgery.

Authors:  David M Shaw; Ainsley M Sutherland; James A Russell; Samuel V Lichtenstein; Keith R Walley
Journal:  Crit Care       Date:  2009-01-29       Impact factor: 9.097

Review 8.  Does intraoperative ulinastatin improve postoperative clinical outcomes in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Qiu-Lan He; Fei Zhong; Fang Ye; Ming Wei; Wei-Feng Liu; Mei-Na Li; Qiao-Bo Li; Wen-Qi Huang; Lai-Bao Sun; Hai-Hua Shu
Journal:  Biomed Res Int       Date:  2014-03-09       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.